Personalized cancer vaccine aims to keep ovarian cancer at bay
NCT ID NCT02346747
Summary
This study is testing whether a personalized vaccine called Vigil can help women with advanced ovarian cancer stay cancer-free longer after their initial surgery and chemotherapy. The vaccine is made from each patient's own tumor cells and is given as a series of injections. Researchers want to see if this approach can delay or prevent the cancer from coming back compared to a placebo injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AMD Asplundh Cancer Pavilion
Abington, Pennsylvania, 19001, United States
-
Barrett Cancer Center University of Cincinnati Medical Center
Cincinnati, Ohio, 45219, United States
-
Billings Clinic
Billings, Montana, 59101, United States
-
Cancer Care Northwest
Spokane, Washington, 99216, United States
-
Dana Farber Cancer Institute: Gynecologic Oncology
Boston, Massachusetts, 02215, United States
-
Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center
Lebanon, New Hampshire, 03756, United States
-
Duke University Medical Center, Department of Medicine - Oncology
Durham, North Carolina, 27710, United States
-
Florida Cancer Specialists
West Palm Beach, Florida, 33401, United States
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, 19111, United States
-
Franciscan Research Center
Tacoma, Washington, 98405, United States
-
Georgia Cancer Center at Augusta University
Augusta, Georgia, 30912, United States
-
Henry Ford Health System
Detroit, Michigan, 48202, United States
-
Maine Medical Center: MMP Women's Health
Scarborough, Maine, 04074, United States
-
Mary Crowley Cancer Research Centers
Dallas, Texas, 75230, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Nebraska Methodist Hospital
Omaha, Nebraska, 68114, United States
-
Palo Alto Foundation Medical Group
San Francisco, California, 94115, United States
-
Prisma Health Cancer Institute
Greenville, South Carolina, 29605, United States
-
Southern California Permanente Medical Group
Irvine, California, 92618, United States
-
St. Luke's Health Network
Bethlehem, Pennsylvania, 18015, United States
-
Stephenson Cancer Center at University of Oklahoma
Oklahoma City, Oklahoma, 73104, United States
-
University Of Kentucky Markey Cancer Center
Lexington, Kentucky, 40536, United States
-
University Of Miami Sylvester Comprehensive Cancer Center
Miami, Florida, 33136, United States
-
University of New Mexico Cancer Center
Albuquerque, New Mexico, 87106, United States
-
University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, 36604, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390-9032, United States
Conditions
Explore the condition pages connected to this study.